## Abstract Drug‐induced phospholipidosis (PLD) is a side effect of the administration of cationic amphiphilic drugs (CADs). It is desirable to identify and screen compounds with the potential to induce PLD as early as possible in drug development. Recently, a number of in silico methods have been
In silico study on the effects of matrix structure in controlled drug release
✍ Scribed by Rafael Villalobos; Salomón Cordero; Ana Maria Vidales; Armando Domínguez
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 320 KB
- Volume
- 367
- Category
- Article
- ISSN
- 0378-4371
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## ABSTRACT The aim of this case study was to develop a drug‐specific absorption model for levothyroxine (LT4) using mechanistic gastrointestinal simulation technology (GIST) implemented in the GastroPlus™ software package. The required input parameters were determined experimentally, __in silico__
acrylic copolymer entrapment product containing 25 % drug, is quite different. The diffraction pattern indicates that crystalline drug is absent. The absence of crystalline drug in this sample demonstrates that the drug in the entrapment product is uniformly dispersed at a molecular level. The mech
The release of fluorescein isothiocyanate labeled bovine serum albumin (FITC-BSA) from alginate-microencapsulated liposomes was studied to evaluate the properties of this system for controlled drug delivery. Liposomes composed of phosphatidylcholine (PC) and cholesterol (Chol) (molar ratio 7:3) and